France· FR:69883296
AMBROXOL EG LABO CONSEIL 0,3 POUR CENT SANS SUCRE, solution buvable édulcorée au cyclamate de sodium et au sorbitol
A medicinal product containing chlorhydrate d'ambroxol, registered in France by EG LABO - LABORATOIRES EUROGENERICS.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- CHLORHYDRATE D'AMBROXOL
- Manufacturer
- EG LABO - LABORATOIRES EUROGENERICS
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- No
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
- cip1334009348878191 flacon(s) en verre brun de 180 ml
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Chlorhydrate d'ambroxol in 11 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaAMBROBENEratiopharm GmbH, Ulm
- PolandAfleganBausch Health Ireland Ltd.
- GermanyAmbrobetaBetapharm Arzneimittel Gmbh
- SpainAMBROXOL ALDO-UNION 15 MG/2 ML SOLUCION ORAL O CONCENTRADO PARA INHALACION POR NEBULIZADORLaboratorio Aldo Union S.L.
- BelgiumAmbroxine 2,5 mg/doseBoehringer Ingelheim
- FinlandAmbroxol ratiopharmTeva B.V.
- United KingdomMucosolvan 30mg tabletsImported (Italy)
- SwedenMucoangin Citron 20 mg SugtablettOpella Healthcare France SAS
Authorised across Europe · EMA
The same active substance is authorised in 26 EEA countries. Names it is sold under:
- Austria · Ambrobene, Ambrohexal
- Belgium · Bisolangin
- Bulgaria · Mукосолван Макс, Амбрекс
- Cyprus · Broxivan, Fluibron
- Czechia · Ambrobene, Ambrosan
- Germany · Ambrobeta, Ambrox
- Denmark · Ambroxolhydrochlorid Teva
- Estonia · Ambrolan, Ambrolytin
- Spain · Ambroxol Aldo-Unión, Ambroxol Cinfa
- Finland · Ambroxol Ratiopharm, Flavamed
- Greece · Abrobion, Aprinol
- Croatia · Brosils, Flavamed
- Hungary · Ambrobene, Ambrobene Liquid
- Iceland · Broksil
- Italy · Ambrotus, Ambroxol Tecnigen
- Lithuania · Ambrolan, Ambrotusin
- Luxembourg · Ambroxol Hustenlöser Ratiopharm, Ambroxol Hustensaft
- Latvia · Ambroksol, Ambrolan
- Malta · Broncoliber, Broncosil
- Norway · Ambroksolhydroklorid Med Lakrissmak Geiser, Ambroksolhydroklorid Med Mintsmak Geiser
- Poland · Aflegan, Ambroksol Apteo Med
- Portugal · Ambroxol Azevedos, Ambroxol Farmoz
- Romania · Ambromed, Ambroxol Al
- Sweden · Ambroksol Lakrits Geiser, Ambroksol Mint Geiser
- Slovenia · Ambroksolijev Klorid Berlin-Chemie, Ambrospray
- Slovakia · Ambrobene, Ambrobene Retard
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/8fc3035e-f66a-4c94-a2c9-abb022d6bc17 GET /v1/drugs/8fc3035e-f66a-4c94-a2c9-abb022d6bc17?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "69883296",
"date_amm": "1998-12-02",
"type_amm": "Procédure nationale",
"numero_ue": null,
"substance": "CHLORHYDRATE D'AMBROXOL",
"statut_amm": "Autorisation abrogée",
"statut_bdm": "Warning disponibilité",
"forme_pharmaceutique": "solution buvable",
"voies_administration": "orale",
"etat_commercialisation": "Non commercialisée",
"surveillance_renforcee": "Non"
}See everything about chlorhydrate d'ambroxol.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.